Blood glucose: A strong risk factor for mortality in nondiabetic patients with cardiovascular disease

American Heart Journal

Volumn 150, Issue 2, 2005, Pages 209-214

  Port, Sidney C ^a   Goodarzi, Mark O ^b   Boyle, Noel G ^b   Jennrich, Robert I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; OBESITY; PROGNOSIS; RISK FACTORS; SMOKING;

EID: 23644456018     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.09.031     Document Type: Article

References (27)

1. S.M. Grundy, I.J. Benjamin, and G.L. Burke Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 100 1999 1134 1146
2. K.T. Khaw, N. Wareham, and R. Luben Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk) BMJ 322 2001 15 18
3. S.P. Marso Optimizing the diabetic formulary: beyond aspirin and insulin J Am Coll Cardiol 40 2002 652 661
4. M. Laakso Hyperglycemia and cardiovascular disease in type 2 diabetes Diabetes 48 1999 937 942
5. H.C. Gerstein, P. Pais, and J. Pogue Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study J Am Coll Cardiol 33 1999 612 619
6. M. Coutinho, H.C. Gerstein, and Y. Wang The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240
7. J.V. Bjornholt, G. Erikssen, and E. Aaser Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men Diabetes Care 22 1999 45 49
8. R.P. Donahue, R.D. Abbott, and D.M. Reed Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program Diabetes 36 1987 689 692
9. M. Tominaga, H. Eguchi, and H. Manaka Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Diabetes Care 22 1999 920 924
10. B. Balkau, S. Bertrais, and P. Ducimetiere Is there a glycemic threshold for mortality risk? Diabetes Care 22 1999 696 699
11. S.E. Capes, D. Hunt, and K. Malmberg Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 2000 773 778
12. D. Zindrou, K.M. Taylor, and J.P. Bagger Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting Diabetes Care 24 2001 1634 1639
13. M. Zeller, Y. Cottin, and M.C. Brindisi Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction Eur Heart J 25 2004 308 312
14. E.Z. Fisman, M. Motro, and A. Tenenbaum Impaired fasting glucose concentration in non-diabetic patients with ischemic heart disease: a marker for a worse prognosis Am Heart J 141 2001 485 490
15. J.B. Muhlestein, J.L. Anderson, and B.D. Horne Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention Am Heart J 146 2003 351 358
16. L. Arcavi, S. Behar, and A. Caspi High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary heart disease: results from the Bezafibrate Infarction Prevention (BIP) study Am Heart J 147 2004 239 245
17. T.R. Dawber The Framingham Study: the epidemiology of atherosclerotic disease 1980 Harvard University Press Cambridge
18. N.A. Nelson Photometric adaptation of the Somogyi method for the determination of glucose J Biol Chem 153 1944 375 380
19. K. Kuwa, T. Nakayama, and T. Hoshino Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma Clin Chim Acta 307 2001 187 192
20. L.A. Cupples, R.B. D'Agostino, and K. Anderson Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study Stat Med 7 1988 205 222
21. R.B. D'Agostino, M.L. Lee, and A.J. Belanger Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study Stat Med 9 1990 1501 1515
22. G.L. King, and H. Wakasaki Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes Diabetes Care 22 Suppl 3 1999 C31 C37
23. M. Pyorala, H. Miettinen, and M. Laakso Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study Circulation 98 1998 398 404
24. M.F. Oliver, and L.H. Opie Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias Lancet 343 1994 155 158
25. R. Jokl, M. Laimins, and R.L. Klein Platelet plasminogen activator inhibitor 1 in patients with type II diabetes Diabetes Care 17 1994 818 823
26. B. Balkau, M. Shipley, and R.J. Jarrett High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-Year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study Diabetes Care 21 1998 360 367
27. M. Wei, L.W. Gibbons, and T.L. Mitchell Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality Circulation 101 2000 2047 2052